Brez internetne povezave — prikazana je shranjena različica strani.
← k velikim vlagateljem

Redmile Group, LLC

upravljavec premoženja · portfelj $1.49 mrd. · 39 pozicij · poročilo na dan 30.06.2026

Pozicije v delnicah poročilo za 30.06.2026, oddano 14.08.2026; sprememba — v primerjavi z 31.03.2026 · 39

PodjetjeDelniceVrednost% portfeljaSprememba v četrtletju
Scholar Rock Holding Corp
US:SRRK
4 311 092$237 mio.15.92%−4 755 529
Krystal Biotech Inc
US:KRYS
632 005$235 mio.15.77%−41 500
Stoke Therapeutics, Inc.
US:STOK
3 945 920$129 mio.8.67%−218 200
Immunome Inc
US:IMNM
4 911 590$104 mio.6.99%−647 295
Nurix Therapeutics Inc
US:NRIX
4 073 787$98.8 mio.6.64%−3 659 021
Absci Corp
US:ABSI
6 739 675$78.1 mio.5.24%−1 513 641
Annexon, Inc.
US:ANNX
11 869 877$67.8 mio.4.55%−2 679 891
Regenxbio Inc
US:RGNX
4 368 804$52.3 mio.3.51%—
Shattuck Labs Inc
US:STTK
6 892 033$47.8 mio.3.21%+1 352 309
Neurogene Inc
US:NGNE
1 412 199$44.4 mio.2.98%−47 400
Beam Therapeutics Inc.
US:BEAM
1 164 259$40.0 mio.2.68%−73 400
AgomAb Therapeutics NV
US:AGMB
2 733 926$35.5 mio.2.38%+2 577 676
Fate Therapeutics Inc
US:FATE
12 872 946$34.8 mio.2.33%—
Ideaya Biosciences Inc
US:IDYA
640 202$23.9 mio.1.60%+119 085
Silence Therapeutics PLC
US:SLN
2 164 777$23.8 mio.1.60%—
Cogent Biosciences Inc
US:COGT
503 321$19.5 mio.1.31%−184 715
Solid Biosciences LLC
US:SLDB
1 948 695$19.5 mio.1.31%−63 200
Nuvation Bio Inc
US:NUVB
3 031 009$17.2 mio.1.16%−122 247
Celldex Therapeutics Inc
US:CLDX
433 921$16.1 mio.1.08%+172 413
Climb Bio Inc
US:CLYM
1 226 330$16.0 mio.1.07%nova
Alx Oncology Holdings 
US:ALXO
7 392 504$15.3 mio.1.03%−571 684
Biomarin Pharmaceutical Inc
US:BMRN
265 169$15.2 mio.1.02%+91 310
Xenon Pharmaceuticals Inc
US:XENE
229 374$13.8 mio.0.93%−33 300
Zymeworks Inc.
US:ZYME
491 654$12.9 mio.0.86%—
ADC THERAPEUTICS SA
CUSIP H0036K147
11 526 710$12.3 mio.0.83%−3 943 792
Aura Biosciences Inc
US:AURA
1 666 667$11.8 mio.0.79%nova
Odyssey Therapeutics, Inc.
US:ODTX
425 000$7.95 mio.0.53%nova
LIVANOVA PLC
CUSIP G5509L101
93 154$7.66 mio.0.51%−15 200
ESTABLISHMENT LABS HLDGS INC
CUSIP G31249108
88 964$7.63 mio.0.51%−14 500
CeriBell, Inc
US:CBLL
386 786$7.52 mio.0.51%—

V podjetjih iz naše baze podatkov 13

PodjetjeDeležDelniceDatum poročila
Fate Therapeutics Inc10.74%12 872 9462026-06-30
ADC Therapeutics SA9.03%11 526 7102026-06-30
Neurogene Inc7.06%1 412 1992026-06-30
Shattuck Labs Inc6.87%6 892 0332026-06-30
Regenxbio Inc6.62%4 368 8042026-06-30
AgomAb Therapeutics NV5.55%2 733 9262026-06-30
Alx Oncology Holdings 5.35%7 392 5042026-06-30
Atara Biotherapeutics Inc4.4%441 7012026-06-30
Immunome Inc4.32%4 911 5902026-06-30
Absci Corp3.93%6 739 6752026-06-30
Silence Therapeutics PLC3.6%2 164 7772026-06-30
Attovia Therapeutics, Inc.——2026-08-06
Scancell Hldgs Plc—297 188 3652026-07-28
oglas